stockrowEledon Pharmaceuticals, Inc. (ELDN) vs Palisade Bio, Inc. (PALI)
- Eledon Pharmaceuticals, Inc. ELDN 2.61 +6.10%
- Palisade Bio, Inc. PALI 1.13 −2.59%
Eledon Pharmaceuticals, Inc. and Palisade Bio, Inc. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. and Palisade Bio, Inc. are of similar size ($202.2M and $199.9M). Eledon Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 1.8×. Eledon Pharmaceuticals, Inc. has the higher net margin (0.00% vs −4,230.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Palisade Bio, Inc. leads on 8 and Eledon Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | ELDN | PALI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 95.63% | 68.51% |
| Operating margin | 0.00% | (4,681.99%) | 0.00% |
| Net margin | 0.00% | (4,230.60%) | 0.00% |
| Free cash flow margin | 0.00% | (2,409.27%) | 0.00% |
| Return on equity | (236.51%) | (51.37%) | (51.96%) |
| Return on assets | (72.74%) | (47.68%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack